135 related articles for article (PubMed ID: 35800421)
1. Incidental Synchronous
Roshanravan V; Soltani E; Hasanzadeh Haddad E; Sadeghi R; Sahebkari A; Mottaghi M; Aghaee A
Asia Ocean J Nucl Med Biol; 2022; 10(2):138-141. PubMed ID: 35800421
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of
Li B; Duan L; Li X; Shi J; Li H; Liu H; Cheng X; Wu X; Gao Y
Front Oncol; 2023; 13():1228575. PubMed ID: 37554164
[TBL] [Abstract][Full Text] [Related]
3. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
[TBL] [Abstract][Full Text] [Related]
4. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
[TBL] [Abstract][Full Text] [Related]
5. Multiple Cutaneous Metastases on
Sankar G; Rajaraman V; Ganesh RN; Halanaik D; Pandit N; Ponnusamy M
Indian J Nucl Med; 2018; 33(4):348-350. PubMed ID: 30386061
[TBL] [Abstract][Full Text] [Related]
6. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
[TBL] [Abstract][Full Text] [Related]
7. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of
Chen H; Li Y; Gao X; Shen X
Clin Imaging; 2018; 52():365-369. PubMed ID: 30248495
[TBL] [Abstract][Full Text] [Related]
9. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
Rasgon BM
Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
Jois B; Asopa R; Basu S
Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
[TBL] [Abstract][Full Text] [Related]
11. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
[TBL] [Abstract][Full Text] [Related]
12. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
[TBL] [Abstract][Full Text] [Related]
13. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan.
Jing H; Li F; Zhuang H; Wang Z; Tian J; Xing X; Jin J; Zhong D; Zhang J
Eur J Radiol; 2013 Nov; 82(11):2028-34. PubMed ID: 23721625
[TBL] [Abstract][Full Text] [Related]
14. Microcystic Serous Cystadenoma Masquerading as Pancreatic Neuroendocrine Tumor on 99m Tc-HYNIC-TOC SPECT/CT.
Cai W; Dong Y; Zhao T; Dong A; Zhao Q
Clin Nucl Med; 2024 Feb; 49(2):e87-e89. PubMed ID: 38048519
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node scintigraphy in cutaneous melanoma using a planar calibration phantom filled with Tc-99m pertechnetate solution for body contouring.
Peştean C; Bărbuş E; Piciu A; Larg MI; Sabo A; Moisescu-Goia C; Piciu D
Clujul Med; 2016; 89(4):480-485. PubMed ID: 27857516
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node identification with radiopharmaceuticals in patients with breast cancer: a comparison of 99mTc-tin colloid and 99mTc-phytate efficiency.
Seok JW; Choi YS; Chong S; Kwon GY; Chung YJ; Kim BG; Park SJ
Breast Cancer Res Treat; 2010 Jul; 122(2):453-7. PubMed ID: 20532977
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of indigenously formulated single-vial lyophilized HYNIC-TOC kit in evaluating Gastro-entero Pancreatic neuro endocrine tumours.
Shinto AS; Kamaleshwaran K; Vyshak K; Sudhakar N; Banerjee S; Korde A; Samuel G; Mallia M
Asia Ocean J Nucl Med Biol; 2014; 2(1):30-41. PubMed ID: 27408857
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
Trogrlic M; Tezak S
Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
